SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mohamad Aljofan, Hendra and Nipah infection: Emerging paramyxoviruses, Virus Research, 2013, 177, 2, 119

    CrossRef

  2. 2
    M. Afshar, A.D. Martinez, R.L. Gallo, T.R. Hata, Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: A review and analysis of 36 cases, Journal of the European Academy of Dermatology and Venereology, 2013, 27, 6
  3. 3
    G. Novelli, M. Rossi, V. Morabito, G. Ferretti, R. Pretagostini, F. Ruberto, F. Pugliese, N. Guglielmo, P.B. Berloco, Management of Hepatitis C Virus Infection in Liver Transplantation with Adacolumn Apheresis, Transplantation Proceedings, 2012, 44, 7, 1946

    CrossRef

  4. 4
    Patricia Sheiner, Caroline Rochon, Recurrent Hepatitis C After Liver Transplantation, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2012, 79, 2
  5. 5
    P. Guillouche, C. Féray, Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation, Alimentary Pharmacology & Therapeutics, 2011, 33, 2
  6. 6
    Yasuhiko Sugawara, Sumihito Tamura, Norihiro Kokudo, Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation, Hepatitis Research and Treatment, 2010, 2010, 1

    CrossRef

  7. 7
    Raffaella Lionetti, Giuseppe Tisone, Giampiero Palmieri, Cristiana Almerighi, Alessandra Anselmo, Laura Tariciotti, Ilaria Lenci, Linda De Luca, Andrea Monaco, Mario Angelico, Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression, Digestive and Liver Disease, 2010, 42, 4, 297

    CrossRef

  8. 8
    Ashok Jain, Rajeev Sharma, Charlotte Ryan, Saman Safadjou, Randeep Kashyap, Parvez Mantry, Benedict Maliakkal, Mark Orloff, Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience, Clinical Transplantation, 2010, 24, 1
  9. 9
    Hui-Hui Tan, Thomas D. Schiano, Treatment of hepatitis C in the potential liver transplant recipient, Current Hepatitis Reports, 2009, 8, 2, 81

    CrossRef

  10. 10
    F. LODATO, S. BERARDI, A. GRAMENZI, G. MAZZELLA, M. LENZI, M. C. MORELLI, M. R. TAME, F. PISCAGLIA, P. ANDREONE, G. BALLARDINI, M. BERNARDI, F. B. BIANCHI, M. BISELLI, L. BOLONDI, M. CESCON, A. COLECCHIA, A. D’ERRICO, M. DEL GAUDIO, G. ERCOLANI, G. L. GRAZI, W. GRIGIONI, S. LORENZINI, A. D. PINNA, M. RAVAIOLI, E. RODA, C. SAMA, M. VIVARELLI, Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation, Alimentary Pharmacology & Therapeutics, 2008, 28, 4
  11. 11
    Mohamad Aljofan, Matteo Porotto, Anne Moscona, Bruce A. Mungall, Development and validation of a chemiluminescent immunodetection assay amenable to high throughput screening of antiviral drugs for Nipah and Hendra virus, Journal of Virological Methods, 2008, 149, 1, 12

    CrossRef

  12. 12
    Bruno Roche, Mylene Sebagh, Maria Laura Canfora, Teresa Antonini, Anne-Marie Roque-Afonso, Valerie Delvart, Faouzi Saliba, Jean-Charles Duclos-Vallee, Denis Castaing, Didier Samuel, Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis, Liver Transplantation, 2008, 14, 12
  13. 13
    B. J. Veldt, J. J. Poterucha, K. D. S. Watt, R. H. Wiesner, J. E. Hay, W. K. Kremers, C. B. Rosen, J. K. Heimbach, M. R. Charlton, Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection, American Journal of Transplantation, 2008, 8, 11
  14. 14
    L. Margusino Framiñán, F. Suárez López, I. Martín Herranz, Profilaxis y tratamiento de la hepatopatía por virus C en el entorno del trasplante hepático. Revisión narrativa, Farmacia Hospitalaria, 2008, 32, 2, 102

    CrossRef

  15. 15
    F. TEKIN, F. GUNSAR, Z. KARASU, U. AKARCA, G. ERSOZ, Safety, tolerability, and efficacy of pegylated-interferon alfa-2a plus ribavirin in HCV-related decompensated cirrhotics, Alimentary Pharmacology & Therapeutics, 2008, 27, 11
  16. 16
    Luis Margusino Framiñán, Francisco Suárez López, Isabel Martín Herranz, The Profilaxis and Treatment of C Virus Liver Disease in the Liver Transplantation Setting. Narrative Review, Farmacia Hospitalaria (English Edition), 2008, 32, 2, 102

    CrossRef

  17. 17
    Sumihito Tamura, Yasuhiko Sugawara, Treatment strategy for hepatitis C after liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  18. 18
    Mario Angelico, Alessandra Petrolati, Raffaella Lionetti, Ilaria Lenci, Patrizia Burra, Maria Francesca Donato, Manuela Merli, Mario Strazzabosco, Giuseppe Tisone, A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C, Journal of Hepatology, 2007, 46, 6, 1009

    CrossRef

  19. 19
    Sammy Saab, Mina K. Oh, Ayman B. Ibrahim, Francisco Durazo, Steven Han, Hasan Yersiz, Douglas G. Farmer, R. Mark Ghobrial, Leonard I. Goldstein, Myron J. Tong, Ronald W. Busuttil, Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C, Liver Transplantation, 2007, 13, 7
  20. 20
    José A. Carrión, Miquel Navasa, Montserrat García–Retortillo, Juan Carlos García–Pagan, Gonzalo Crespo, Miquel Bruguera, Jaime Bosch, Xavier Forns, Efficacy of Antiviral Therapy on Hepatitis C Recurrence After Liver Transplantation: A Randomized Controlled Study, Gastroenterology, 2007, 132, 5, 1746

    CrossRef

  21. 21
    Marina Berenguer, Management of Hepatitis C Virus in the Transplant Patient, Clinics in Liver Disease, 2007, 11, 2, 355

    CrossRef

  22. 22
    Nyingi Kemmer, Guy W. Neff, Managing chronic hepatitis C in the difficult-to-treat patient, Liver International, 2007, 27, 10
  23. 23
    T. Walter, J. Dumortier, O. Guillaud, V. Hervieu, P. Paliard, J.-Y. Scoazec, O. Boillot, Rejection Under Alpha Interferon Therapy in Liver Transplant Recipients, American Journal of Transplantation, 2007, 7, 1
  24. 24
    Rosângela Teixeira, Érica Godinho Menezes, Thomas D. Schiano, Therapeutic management of recurrent hepatitis C after liver transplantation, Liver International, 2007, 27, 3
  25. 25
    P. Burra, S. Targhetta, S. Pevere, S. Boninsegna, M. Guido, D. Canova, A. Brolese, A. Masier, C. D’Aloiso, G. Germani, S. Tomat, S. Fagiuoli, Antiviral Therapy for Hepatitis C Virus Recurrence Following Liver Transplantation: Long-Term Results From a Single Center Experience, Transplantation Proceedings, 2006, 38, 4, 1127

    CrossRef

  26. 26
    Bruno Roche, Didier Samuel, Aspects of hepatitis C virus infection relating to liver transplantation, European Journal of Gastroenterology & Hepatology, 2006, 18, 4, 313

    CrossRef

  27. 27
    Inmaculada Fernández, Juan Carlos Meneu, Francisco Colina, Ignacio García, Raquel Muñoz, Gregorio Castellano, Antonio Fuertes, Manuel Abradelo, Carlos Lumbreras, Enrique Moreno, José Antonio Solís-Herruzo, Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation, Liver Transplantation, 2006, 12, 12
  28. 28
    Tarik Asselah, Hamza Boudjema, Claire Francoz, Rodolphe Sobesky, Dominique Valla, Jacques Belghiti, Patrick Marcellin, François Durand, Hépatite C et transplantation hépatique, Gastroentérologie Clinique et Biologique, 2006, 30, 11, 1281

    CrossRef

  29. 29
    C. S. Wang, H. H. Ko, E. M. Yoshida, C. A. Marra, K. Richardson, Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative Analysis, American Journal of Transplantation, 2006, 6, 7
  30. 30
    Sakib K. Khalid, Jeffrey S. Crippin, Management of Hepatitis C in the Setting of Liver Transplantation, Clinics in Liver Disease, 2006, 10, 2, 321

    CrossRef

  31. 31
    Mandana Khalili, Andrew J Vardanian, Chris M Hamerski, Rou Wang, Peter Bacchetti, John P Roberts, Norah A Terrault, Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years, Clinical Transplantation, 2006, 20, 1
  32. 32
    Scott W. Biggins, Norah A. Terrault, Management of Recurrent Hepatitis C in Liver Transplant Recipients, Infectious Disease Clinics of North America, 2006, 20, 1, 155

    CrossRef

  33. 33
    Marina Berenguer, Manejo de la infección por el virus de la hepatitis C en el trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 7, 422

    CrossRef

  34. 34
    Thomas D. Schiano, Michael Charlton, Zobair Younossi, Eithan Galun, Timothy Pruett, Ran Tur-Kaspa, Rachel Eren, Shlomo Dagan, Neil Graham, Paulette V. Williams, John Andrews, Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study, Liver Transplantation, 2006, 12, 9
  35. 35
    M. Heydtmann, D. Freshwater, T. Dudley, V. Lai, S. Palmer, S. Hübscher, D. Mutimer, Pegylated Interferon Alpha-2b for Patients with HCV Recurrence and Graft Fibrosis Following Liver Transplantation, American Journal of Transplantation, 2006, 6, 4
  36. 36
    J. Dumortier, E. Ducos, J.-Y. Scoazec, P. Chevallier, O. Boillot, M.-C. Gagnieu, Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon α-2b and ribavirin combination after liver transplantation, Journal of Viral Hepatitis, 2006, 13, 8
  37. 37
    Naondo Sohara, Hitoshi Takagi, Satoru Kakizaki, Ken Sato, Masatomo Mori, The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia, Transplant International, 2006, 19, 3
  38. 38
    M. Berenguer, Tratamiento de la hepatitis C antes y después del trasplante hepático, Gastroenterología y Hepatología, 2006, 29, 190

    CrossRef

  39. 39
    Gregory T. Everson, Antiviral therapy in the liver transplant candidate and recipient, Current Hepatitis Reports, 2005, 4, 2, 75

    CrossRef

  40. 40
    Amandeep K. Shergill, Mandana Khalili, Stephanie Straley, Kathy Bollinger, John P. Roberts, Nancy A. Ascher, Norah A. Terrault, Applicability, Tolerability and Efficacy of Preemptive Antiviral Therapy in Hepatitis C-Infected Patients Undergoing Liver Transplantation, American Journal of Transplantation, 2005, 5, 1
  41. 41
    Samer Gawrieh, Bettina G. Papouchado, Lawrence J. Burgart, Shogo Kobayashi, Michael R. Charlton, Gregory J. Gores, Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation, Liver Transplantation, 2005, 11, 10
  42. 42
    Aileen Marshall, Simon Rushbrook, Lesley S. Morris, Ian S. Scott, Sarah L. Vowler, Susan E. Davies, Nicholas Coleman, Graeme Alexander, Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study, Liver Transplantation, 2005, 11, 4
  43. 43
    Isabelle Morard, Francesco Negro, How should we treat recurrent hepatitis C after liver transplantation?, Journal of Hepatology, 2005, 42, 4, 462

    CrossRef

  44. 44
    Bijan Eghtesad, John J. Fung, Anthony J. Demetris, Noriko Murase, Roberta Ness, Debra C. Bass, Edward A. Gray, Obaid Shakil, Bridget Flynn, Amadeo Marcos, Thomas E. Starzl, Immunosuppression for liver transplantation in HCV-infected patients: Mechanism-based principles, Liver Transplantation, 2005, 11, 11
  45. 45
    Hector Rodriguez-Luna, Hugo E. Vargas, Management of hepatitis C virus infection in the setting of liver transplantation, Liver Transplantation, 2005, 11, 5
  46. 46
    T Ichida, Y Shimada, H Mori, M Ishikawa, K Ogawa, Present condition of liver transplantation and future problem. 9. HCV reinfection after liver transplantation. Present states and measures., Kanzo, 2005, 46, 6, 344

    CrossRef

  47. 47
    Takafumi ICHIDA, Reinfection of hepatitis C and measures., Kanzo, 2005, 46, 9, 529

    CrossRef

  48. 48
    A. Jain, R. Vekatramanan, B. Yelochan, R. Kashyap, A. Marcos, J. Fung, Ribavirin Levels in Post Liver Transplant Patients Treated for Recurrent Hepatitis C Viral Infection, Transplantation Proceedings, 2005, 37, 7, 3190

    CrossRef

  49. 49
    R Todd Fredrick, Tarek I Hassanein, Role of Growth Factors in the Treatment of Patients With HIV/HCV Coinfection and Patients With Recurrent Hepatitis C Following Liver Transplantation, Journal of Clinical Gastroenterology, 2005, 39, Supp 1, S14

    CrossRef

  50. 50
    Andrew I. Kim, Sammy Saab, Treatment of hepatitis C, The American Journal of Medicine, 2005, 118, 8, 808

    CrossRef

  51. 51
    Marina Berenguer, Treatment of Hepatitis C after Liver Transplantation, Clinics in Liver Disease, 2005, 9, 4, 579

    CrossRef

  52. 52
    Jens Encke, Thomas Kraus, Arianeb Mehrabi, Wolfgang Stremmel, Peter Sauer, Treatment of Hepatitis C Virus Reinfection after Liver Transplantation, Transplantation, 2005, 80, Supplement, S125

    CrossRef

  53. 53
    Bruno Roche, Didier Samuel, Treatment of hepatitis�B and C after liver transplantation. Part 2, hepatitis�C, Transplant International, 2005,

    CrossRef

  54. 54
    Scott W. Biggins, Norah A. Terrault, Treatment of Recurrent Hepatitis C After Liver Transplantation, Clinics in Liver Disease, 2005, 9, 3, 505

    CrossRef

  55. 55
    Matthias J. Bahr, Michael P. Manns, Changing faces—natural course and treatment of hepatitis C after liver transplantation, Journal of Hepatology, 2004, 40, 4, 699

    CrossRef

  56. 56
    Doris B. Strader, Teresa Wright, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, 2004, 39, 4
  57. 57
    Didier Samuel, Hepatitis C, interferon, and risk of rejection after liver transplantation, Liver Transplantation, 2004, 10, 7
  58. 58
    Andrew S Ross, Atul K Bhan, Manuel Pascual, Michael Thiim, A Benedict Cosimi, Raymond T Chung, Pegylated interferon α-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C, Clinical Transplantation, 2004, 18, 2
  59. 59
    Montserrat Garcia-Retortillo, Xavier Forns, Prevention and treatment of hepatitis C virus recurrence after liver transplantation, Journal of Hepatology, 2004, 41, 1, 2

    CrossRef

  60. 60
    Emiliano Giostra, Gerd A. Kullak-Ublick, Walter Keller, Ronald Fried, Claire Vanlemmens, Stephan Kraehenbuhl, Sandrine Locher, Hans-Peter Egger, Pierre-Alain Clavien, Antoine Hadengue, Gilles Mentha, Philippe Morel, Francesco Negro, Ribavirin/interferon-α sequential treatment of recurrent hepatitis C after liver transplantation, Transplant International, 2004, 17, 4
  61. 61
    Bruno Roche, Didier Samuel, Treatment of hepatitis B and C after liver transplantation. Part 2, hepatitis C, Transplant International, 2004, 17, 12
  62. 62
    Jérôme Dumortier, Jean-Yves Scoazec, Philippe Chevallier, Olivier Boillot, Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination, Journal of Hepatology, 2004, 40, 4, 669

    CrossRef

  63. 63
    Hector Rodriguez-Luna, Amer Khatib, Pratima Sharma, Giovanni De Petris, James W. Williams, Jose Ortiz, Kathleen Hansen, David Mulligan, Adyr Moss, David D. Douglas, Vijayan Balan, Jorge Rakela, Hugo E. Vargas, Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon ??2b and ribavirin: an open-label series1, Transplantation, 2004, 77, 2, 190

    CrossRef

  64. 64
    Michelle M. Lipman, Scott J. Cotler, Antiviral therapy for hepatitis C, Current Treatment Options in Gastroenterology, 2003, 6, 6, 445

    CrossRef

  65. 65
    Xavier Forns, Montserrat Garcı́a-Retortillo, Trinidad Serrano, Anna Feliu, Francisco Suarez, Manuel de la Mata, Juan Carlos Garcı́a-Valdecasas, Miquel Navasa, Antoni Rimola, Juan Rodés, Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation, Journal of Hepatology, 2003, 39, 3, 389

    CrossRef

  66. 66
    Kimberly A. Brown, Dilip Moonka, Liver transplantation, Current Opinion in Gastroenterology, 2003, 19, 3, 259

    CrossRef

  67. 67
    Lafaine Grant, Jeffrey S. Crippin, Treatment of hepatitis C virus in the liver transplant recipient, Current Treatment Options in Gastroenterology, 2003, 6, 6, 517

    CrossRef

  68. 68
    Aijaz Ahmed, Emmet B. Keeffe, Upodate on chronic hepatitis C, Comprehensive Therapy, 2003, 29, 4, 224

    CrossRef